Fluvoxamine for COVID-19?

. 2021 May 3;63(1623):69-70.

No authors listed

No authors listed. Med Lett Drugs Ther. 2021.

. 2021 May 3;63(1623):69-70.

No abstract available

Keywords: COVID-19; Luvox; SSRIs; Veklury; adverse effects; dosage; efficacy; fluvoxamine; remdesivir; safety.

Similar articles

Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence.
Facente SN, Reiersen AM, Lenze EJ, Boulware DR, Klausner JD. Facente SN, et al. Drugs. 2021 Dec;81(18):2081-2089. doi: 10.1007/s40265-021-01636-5. Epub 2021 Dec 1. Drugs. 2021. PMID: 34851510 Free PMC article. Review.
Fluvoxamine for symptomatic outpatients with COVID-19.
Wu PE, Austin E, Leong D. Wu PE, et al. CMAJ. 2022 Feb 22;194(7):E258. doi: 10.1503/cmaj.220011. Epub 2022 Jan 19. CMAJ. 2022. PMID: 35045990 Free PMC article. Review. No abstract available.
Do the Selective Serotonin Reuptake Inhibitor Antidepressants Fluoxetine and Fluvoxamine Reduce Mortality Among Patients With COVID-19?
Hoertel N. Hoertel N. JAMA Netw Open. 2021 Nov 1;4(11):e2136510. doi: 10.1001/jamanetworkopen.2021.36510. JAMA Netw Open. 2021. PMID: 34779851 No abstract available.
Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials.
Sánchez-Rico M, Rezaei K, Lenze EJ, Limosin F, Hoertel N. Sánchez-Rico M, et al. Ann Pharmacother. 2024 Nov;58(11):1153-1155. doi: 10.1177/10600280231211304. Epub 2023 Nov 28. Ann Pharmacother. 2024. PMID: 38014845 No abstract available.
Fluvoxamine and long COVID: Post-acute recovery.
Reiersen AM, Zorumski CF, Lenze EJ. Reiersen AM, et al. Rev Med Virol. 2024 Jul;34(4):e2557. doi: 10.1002/rmv.2557. Rev Med Virol. 2024. PMID: 38825753 No abstract available.

Fluvoxamine for the treatment of COVID-19.
Nyirenda JL, Sofroniou M, Toews I, Mikolajewska A, Lehane C, Monsef I, Abu-Taha A, Maun A, Stegemann M, Schmucker C. Nyirenda JL, et al. Cochrane Database Syst Rev. 2022 Sep 14;9(9):CD015391. doi: 10.1002/14651858.CD015391. Cochrane Database Syst Rev. 2022. PMID: 36103313 Free PMC article.